Annual FCF
-$541.14 M
-$80.17 M-17.39%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual free cash flow is -$541.14 million, with the most recent change of -$80.17 million (-17.39%) on December 31, 2023.
- During the last 3 years, SAGE annual FCF has fallen by -$1.21 billion (-181.50%).
- SAGE annual FCF is now -181.50% below its all-time high of $663.93 million, reached on December 31, 2020.
Performance
SAGE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$82.36 M
-$1.93 M-2.40%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly free cash flow is -$82.36 million, with the most recent change of -$1.93 million (-2.40%) on September 30, 2024.
- Over the past year, SAGE quarterly FCF has dropped by -$1.93 million (-2.40%).
- SAGE quarterly FCF is now -108.15% below its all-time high of $1.01 billion, reached on December 31, 2020.
Performance
SAGE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$320.04 M
+$53.83 M+14.40%
September 30, 2024
Summary
- As of February 7, 2025, SAGE TTM free cash flow is -$320.04 million, with the most recent change of +$53.83 million (+14.40%) on September 30, 2024.
- Over the past year, SAGE TTM FCF has increased by +$53.83 million (+14.40%).
- SAGE TTM FCF is now -143.82% below its all-time high of $730.29 million, reached on September 30, 2021.
Performance
SAGE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SAGE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.4% | -2.4% | +14.4% |
| 3 y3 years | -181.5% | -19.7% | -143.8% |
| 5 y5 years | -105.3% | +37.0% | +40.1% |
SAGE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.0% | at low | -117.7% | +46.5% | at high | +41.7% |
| 5 y | 5-year | -181.5% | at low | -108.2% | +46.5% | -143.8% | +41.7% |
| alltime | all time | -181.5% | at low | -108.2% | +46.5% | -143.8% | +41.7% |
Sage Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$82.36 M(+2.4%) | -$320.04 M(-14.4%) |
| Jun 2024 | - | -$80.44 M(+112.6%) | -$373.87 M(-12.0%) |
| Mar 2024 | - | -$37.83 M(-68.3%) | -$425.06 M(-21.5%) |
| Dec 2023 | -$541.14 M(+17.4%) | -$119.41 M(-12.3%) | -$541.14 M(-1.4%) |
| Sep 2023 | - | -$136.19 M(+3.5%) | -$548.95 M(+3.2%) |
| Jun 2023 | - | -$131.63 M(-14.5%) | -$531.98 M(+4.9%) |
| Mar 2023 | - | -$153.91 M(+21.0%) | -$506.91 M(+10.0%) |
| Dec 2022 | -$460.97 M(+21.8%) | -$127.21 M(+6.7%) | -$460.97 M(+6.9%) |
| Sep 2022 | - | -$119.23 M(+11.9%) | -$431.26 M(+13.2%) |
| Jun 2022 | - | -$106.56 M(-1.3%) | -$380.86 M(+1.0%) |
| Mar 2022 | - | -$107.97 M(+10.7%) | -$377.06 M(-0.3%) |
| Dec 2021 | -$378.55 M(-157.0%) | -$97.50 M(+41.7%) | -$378.18 M(-151.8%) |
| Sep 2021 | - | -$68.83 M(-33.0%) | $730.29 M(+3.1%) |
| Jun 2021 | - | -$102.77 M(-5.8%) | $708.10 M(+2.4%) |
| Mar 2021 | - | -$109.09 M(-110.8%) | $691.82 M(+4.2%) |
| Dec 2020 | $663.93 M(-224.2%) | $1.01 B(-1210.8%) | $663.93 M(-243.0%) |
| Sep 2020 | - | -$91.02 M(-23.6%) | -$464.13 M(-7.9%) |
| Jun 2020 | - | -$119.05 M(-13.1%) | -$503.76 M(-3.2%) |
| Mar 2020 | - | -$136.97 M(+17.0%) | -$520.23 M(-2.7%) |
| Dec 2019 | -$534.46 M(+102.8%) | -$117.10 M(-10.4%) | -$534.46 M(+2.8%) |
| Sep 2019 | - | -$130.64 M(-3.6%) | -$519.94 M(+10.5%) |
| Jun 2019 | - | -$135.53 M(-10.4%) | -$470.49 M(+40.2%) |
| Mar 2019 | - | -$151.19 M(+47.4%) | -$335.50 M(+27.3%) |
| Dec 2018 | -$263.53 M | -$102.59 M(+26.4%) | -$263.53 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$81.19 M(>+9900.0%) | -$220.65 M(+18.8%) |
| Jun 2018 | - | -$537.00 K(-99.3%) | -$185.79 M(-24.0%) |
| Mar 2018 | - | -$79.22 M(+32.7%) | -$244.41 M(+10.8%) |
| Dec 2017 | -$220.64 M(+83.7%) | -$59.70 M(+28.9%) | -$220.64 M(+13.0%) |
| Sep 2017 | - | -$46.33 M(-21.7%) | -$195.23 M(+8.6%) |
| Jun 2017 | - | -$59.15 M(+6.7%) | -$179.76 M(+21.6%) |
| Mar 2017 | - | -$55.45 M(+61.7%) | -$147.78 M(+23.0%) |
| Dec 2016 | -$120.10 M(+69.4%) | -$34.30 M(+11.1%) | -$120.10 M(+15.5%) |
| Sep 2016 | - | -$30.86 M(+13.6%) | -$103.96 M(+12.3%) |
| Jun 2016 | - | -$27.16 M(-2.2%) | -$92.59 M(+10.3%) |
| Mar 2016 | - | -$27.78 M(+53.0%) | -$83.94 M(+18.4%) |
| Dec 2015 | -$70.88 M(+160.9%) | -$18.16 M(-6.9%) | -$70.88 M(+15.4%) |
| Sep 2015 | - | -$19.49 M(+5.3%) | -$61.44 M(+24.1%) |
| Jun 2015 | - | -$18.51 M(+25.8%) | -$49.51 M(+36.5%) |
| Mar 2015 | - | -$14.72 M(+68.9%) | -$36.27 M(+33.5%) |
| Dec 2014 | -$27.17 M(+55.1%) | -$8.71 M(+15.2%) | -$27.17 M(+15.6%) |
| Sep 2014 | - | -$7.56 M(+43.4%) | -$23.50 M(+11.3%) |
| Jun 2014 | - | -$5.28 M(-6.1%) | -$21.10 M(+5.0%) |
| Mar 2014 | - | -$5.62 M(+11.5%) | -$20.09 M(+14.7%) |
| Dec 2013 | -$17.52 M(+93.9%) | -$5.04 M(-2.6%) | -$17.52 M(+40.4%) |
| Sep 2013 | - | -$5.17 M(+21.2%) | -$12.48 M(+70.7%) |
| Jun 2013 | - | -$4.27 M(+40.2%) | -$7.31 M(+140.2%) |
| Mar 2013 | - | -$3.04 M | -$3.04 M |
| Dec 2012 | -$9.04 M | - | - |
FAQ
- What is Sage Therapeutics annual free cash flow?
- What is the all time high annual FCF for Sage Therapeutics?
- What is Sage Therapeutics annual FCF year-on-year change?
- What is Sage Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Sage Therapeutics?
- What is Sage Therapeutics quarterly FCF year-on-year change?
- What is Sage Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Sage Therapeutics?
- What is Sage Therapeutics TTM FCF year-on-year change?
What is Sage Therapeutics annual free cash flow?
The current annual FCF of SAGE is -$541.14 M
What is the all time high annual FCF for Sage Therapeutics?
Sage Therapeutics all-time high annual free cash flow is $663.93 M
What is Sage Therapeutics annual FCF year-on-year change?
Over the past year, SAGE annual free cash flow has changed by -$80.17 M (-17.39%)
What is Sage Therapeutics quarterly free cash flow?
The current quarterly FCF of SAGE is -$82.36 M
What is the all time high quarterly FCF for Sage Therapeutics?
Sage Therapeutics all-time high quarterly free cash flow is $1.01 B
What is Sage Therapeutics quarterly FCF year-on-year change?
Over the past year, SAGE quarterly free cash flow has changed by -$1.93 M (-2.40%)
What is Sage Therapeutics TTM free cash flow?
The current TTM FCF of SAGE is -$320.04 M
What is the all time high TTM FCF for Sage Therapeutics?
Sage Therapeutics all-time high TTM free cash flow is $730.29 M
What is Sage Therapeutics TTM FCF year-on-year change?
Over the past year, SAGE TTM free cash flow has changed by +$53.83 M (+14.40%)